학술논문

A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
Document Type
Article
Source
In: European Neuropsychopharmacology. (European Neuropsychopharmacology, May 2024, 82:35-43)
Subject
Language
English
ISSN
18737862
0924977X